Dian Diagnostics GroupLtd Past Earnings Performance
Past criteria checks 2/6
Dian Diagnostics GroupLtd has been growing earnings at an average annual rate of 3.5%, while the Healthcare industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 16.3% per year. Dian Diagnostics GroupLtd's return on equity is 4.1%, and it has net margins of 1.3%.
Key information
3.5%
Earnings growth rate
3.1%
EPS growth rate
| Healthcare Industry Growth | 7.0% |
| Revenue growth rate | 16.3% |
| Return on equity | 4.1% |
| Net Margin | 1.3% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Dian Diagnostics GroupLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 13,150 | 170 | 2,623 | 405 |
| 31 Dec 23 | 13,408 | 307 | 2,676 | 433 |
| 30 Sep 23 | 14,945 | -463 | 2,660 | 475 |
| 30 Jun 23 | 16,371 | 8 | 2,777 | 565 |
| 31 Mar 23 | 18,865 | 841 | 2,913 | 623 |
| 01 Jan 23 | 20,282 | 1,434 | 3,122 | 638 |
| 30 Sep 22 | 19,374 | 2,358 | 3,233 | 626 |
| 30 Jun 22 | 18,045 | 2,316 | 3,068 | 547 |
| 31 Mar 22 | 14,863 | 1,578 | 2,675 | 464 |
| 01 Jan 22 | 13,083 | 1,163 | 2,387 | 425 |
| 30 Sep 21 | 12,515 | 1,136 | 2,089 | 402 |
| 30 Jun 21 | 11,967 | 1,029 | 1,990 | 359 |
| 31 Mar 21 | 11,985 | 1,135 | 1,973 | 348 |
| 31 Dec 20 | 10,649 | 803 | 1,795 | 319 |
| 30 Sep 20 | 9,716 | 895 | 1,584 | 260 |
| 30 Jun 20 | 8,932 | 601 | 1,516 | 241 |
| 31 Mar 20 | 8,150 | 281 | 1,441 | 220 |
| 31 Dec 19 | 8,453 | 347 | 1,451 | 212 |
| 30 Sep 19 | 8,291 | 448 | 1,507 | 200 |
| 30 Jun 19 | 8,006 | 433 | 1,476 | 190 |
| 31 Mar 19 | 7,593 | 398 | 1,404 | 172 |
| 31 Dec 18 | 6,967 | 389 | 1,288 | 166 |
| 30 Sep 18 | 6,214 | 392 | 1,182 | 147 |
| 30 Jun 18 | 5,640 | 373 | 1,006 | 198 |
| 31 Mar 18 | 5,169 | 356 | 971 | 160 |
| 31 Dec 17 | 5,004 | 350 | 979 | 127 |
| 30 Sep 17 | 4,903 | 325 | 918 | 98 |
| 30 Jun 17 | 4,515 | 308 | 917 | 0 |
| 31 Mar 17 | 4,233 | 279 | 862 | 0 |
| 31 Dec 16 | 3,824 | 263 | 777 | 0 |
| 30 Sep 16 | 3,147 | 238 | 637 | 0 |
| 30 Jun 16 | 2,673 | 221 | 558 | 0 |
| 31 Mar 16 | 2,165 | 188 | 478 | 0 |
| 31 Dec 15 | 1,858 | 175 | 430 | 0 |
| 30 Sep 15 | 1,645 | 161 | 406 | 0 |
| 30 Jun 15 | 1,523 | 151 | 384 | 0 |
| 31 Mar 15 | 1,411 | 132 | 359 | 0 |
| 31 Dec 14 | 1,335 | 125 | 340 | 0 |
| 30 Sep 14 | 1,275 | 113 | 317 | 0 |
| 30 Jun 14 | 1,178 | 103 | 301 | 0 |
| 31 Mar 14 | 1,082 | 90 | 285 | 0 |
| 31 Dec 13 | 1,015 | 86 | 268 | 0 |
| 30 Sep 13 | 936 | 80 | 252 | 0 |
| 30 Jun 13 | 853 | 75 | 227 | 0 |
Quality Earnings: 300244 has high quality earnings.
Growing Profit Margin: 300244's current net profit margins (1.3%) are lower than last year (4.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300244's earnings have grown by 3.5% per year over the past 5 years.
Accelerating Growth: 300244's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300244 had negative earnings growth (-79.7%) over the past year, making it difficult to compare to the Healthcare industry average (-1%).
Return on Equity
High ROE: 300244's Return on Equity (4.1%) is considered low.